Filter by

Search tool

Displaying 221 - 230 of 310
News

#WorldHepatitisDay: EMCDDA joins forces with partners to address viral hepatitis elimination targets

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day (WHD) to increase awareness and understanding of viral hepatitis and the diseases it causes. Read news...
Virus
News

EMCDDA and ECDC join forces to address the challenge of hepatitis

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EMCDDA in Lisbon from 12–16 June. The initiative brings together some 100 specialists in the...
Publications
European Drug Report

European Drug Report 2017: Trends and Developments

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...
Document library

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims...
Document library

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions

It is estimated that ca 4.7 million people living in European Union (EU) and European Economic Area (EEA) countries are chronically infected with the hepatitis B virus (HBV) and 5.6 million have...
Document library

Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England

This scientific article was one of the 2018 EMCDDA scientific award winners, which celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs. This article won the award in...
News

Reversing the HIV epidemic: Europe needs to scale-up prevention, testing and treatment

HIV experts from across the EU will discuss how to reverse the HIV trend and to prepare Europe to achieve the set target of ending AIDS by 2030.
Document library

HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden

In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. NPS injectors in Hungary are at severe risk of blood-borne infections...
News

EMCDDA meeting focuses on quality standards in drug demand reduction

Quality standards in drug demand reduction will be the focus of discussions today at an EMCDDA meeting gathering experts from seven countries. The purpose of the meeting is to present how the...
Document library

New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe

This scoping study was based on a targeted multi-source data collection exercise focusing on the provision of health and drug interventions associated with NPS use and harms, in selected intervention settings across...
Top